Fargnoli, M.C.; Bardazzi, F.; Bianchi, L.; Dapavo, P.; Fabbrocini, G.; Gisondi, P.; Micali, G.; Offidani, A.M.; Pellacani, G.; Skroza, N.;
et al. Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: An Expert Delphi Consensus Statement. J. Clin. Med. 2023, 12, 3545.
https://doi.org/10.3390/jcm12103545
AMA Style
Fargnoli MC, Bardazzi F, Bianchi L, Dapavo P, Fabbrocini G, Gisondi P, Micali G, Offidani AM, Pellacani G, Skroza N,
et al. Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: An Expert Delphi Consensus Statement. Journal of Clinical Medicine. 2023; 12(10):3545.
https://doi.org/10.3390/jcm12103545
Chicago/Turabian Style
Fargnoli, Maria Concetta, Federico Bardazzi, Luca Bianchi, Paolo Dapavo, Gabriella Fabbrocini, Paolo Gisondi, Giuseppe Micali, Anna Maria Offidani, Giovanni Pellacani, Nevena Skroza,
and et al. 2023. "Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: An Expert Delphi Consensus Statement" Journal of Clinical Medicine 12, no. 10: 3545.
https://doi.org/10.3390/jcm12103545
APA Style
Fargnoli, M. C., Bardazzi, F., Bianchi, L., Dapavo, P., Fabbrocini, G., Gisondi, P., Micali, G., Offidani, A. M., Pellacani, G., Skroza, N., Angileri, R. G., Burlando, M., Campanati, A., Carrera, C. G., Chiricozzi, A., Conti, A., Simone, C. D., Di Lernia, V., Errichetti, E.,
... Pinton, P. C.
(2023). Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: An Expert Delphi Consensus Statement. Journal of Clinical Medicine, 12(10), 3545.
https://doi.org/10.3390/jcm12103545